StevenFoungMD
Pediatric Hematology & Oncology • Stanford, CAProfessor, Pathology, Stanford University Medical Center
Are you Dr. Foung?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-725-6610
Summary
- Dr. Steven Foung, MD is a pediatric hematologist/oncologist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.
Education & Training
University of California San Diego School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1976 - 2027
Publications & Presentations
PubMed
- 2 citationsRecombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone.Juthika Kundu, Hoa T Le, Michael Logan, Darren Hockman, Abdolamir Landi
Journal of Hepatology. 2024-12-01 - 1 citationsAn atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.Atish Mukherji, Frank Jühling, Yogy Simanjuntak, Emilie Crouchet, Fabio Del Zompo
Nature Communications. 2024-08-29 - 2 citationsHepatitis E virus seropositivity in an ethnically diverse community blood donor population.Jordan K Mah, MeiLe Keck, Daniel Y Chu, Harini Sooryanarain, Malaya K Sahoo
Vox Sanguinis. 2023-08-01
Press Mentions
- Stanford Pathologists Awarded Several NIH AwardsNovember 22nd, 2021
The ATGL Lipase Cooperates with ABHD5 to Mobilize Lipids for Hepatitis C Virus AssemblyJune 15th, 2020- Hepatitis C Virus Infection Inhibits a Src-Kinase Regulatory Phosphatase and Reduces T Cell Activation in VivoFebruary 24th, 2020
- Join now to see all
Grant Support
- A vaccine design to induce protective B and T cell immunity against hepatitis C virusSTANFORD UNIVERSITY2021–2026
